Irinotecan Kabi 20 mg/ml concentrate for solution for infusion
Country: Bulgaria
Language: Bulgarian
Source: Изпълнителна агенция по лекарствата
Patient Information leaflet
(PIL)
26-09-2022
Summary of Product characteristics
(SPC)
26-09-2022
Active ingredient:
Иринотекан
Available from:
Fresenius Kabi Oncology Plc.
ATC code:
L01XX19
INN (International Name):
Irinotecan
Dosage:
20 mg/ml concentrate for solution for infusion
Product summary:
Irinotecan Kabi, 20 mg/ml concentrate for solution for infusion - 2 ml x 1;2 ml x 5; 5 ml x 1; 5 ml x 5
Authorization date:
2013-12-18
